XXII 22nd Century Group, Inc. logo

XXII 22nd Century Group, Inc.

Consumer Defensive
$0.60-0.30%ClosedMarket Cap: $99,646

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.02

P/S

0.01

EV/EBITDA

0.79

DCF Value

$-9.52

FCF Yield

-7969.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

-36.7%

Operating Margin

-133.9%

Net Margin

-44.9%

ROE

-25.0%

ROA

-13.2%

ROIC

-52.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$4.1M$-3.3M$
Q4 null$1.0M$-2.8M$
FY null$7.0M$-5.1M$
Q3 null$1.5M$5.5M$

Analyst Ratings

View All

Consensus

Target (Consensus)

$1,237.50

Target (Median)

$1,237.50

Target Range

$1,125.00 - $1,350.00

0 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Arno Andrewdirector
SellFri Nov 14
Arno Andrewdirector
SellFri Nov 14
Staffeldt Jonathanofficer: VP and Deputy General Counsel
SellThu Nov 13
Staffeldt Jonathanofficer: VP and Deputy General Counsel
SellThu Nov 13
SALHANY LUCILLE Sdirector
SellThu Nov 13

Company Info

Sector

Consumer Defensive

Industry

Tobacco

Country

US

Exchange

Beta

0.77

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

Peers